Nebivolol effects on myocardial remodelling, inflammation markers and endothelial dysfunction in chronic heart failure patients with or without Type 2 diabetes mellitus
In patients with chronic heart failure (CHF), persistent neuro-humoral activation of sympatho-adrenal system and hyperglycaemia facilitate the activation of pro-cytokine inflammation component, as one of the pathophysiological mechanisms of endothelial dysfunction (ED). Aim. To study nebivolol effec...
Main Authors: | Yu. N. Belenkov, E. V. Privalova, I. S. Chekneva, L. V. Knyazeva, N. S. Suleymanova, I. V. Vasilyeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2011-02-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1466 |
Similar Items
-
Metabolic disturbances and endothelial function in elderly patients with systolic and diastolic chronic heart failure
by: I. A. Sukmanova, et al.
Published: (2009-10-01) -
Selective beta-blocker bisoprolol: effectiveness and safety in complex treatment of patients with chronic heart failure and Type 2 diabetes mellitus. RAMBO-DM CHF Study results
by: Yu. V. Lapina, et al.
Published: (2008-08-01) -
Relation of the heart remodeling and endothelial dysfunction in chronic heart failure patients
by: Ch. A. Abdullaeva, et al.
Published: (2016-02-01) -
Nebivolol i dislipidemiya u bol'nykh sakharnym diabetom 2 tipa
by: Ivan Ivanovich Dedov, et al.
Published: (2001-03-01) -
Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place
by: L. I. Olbinskaya, et al.
Published: (2007-02-01)